"Membrane Glycoproteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glycoproteins found on the membrane or surface of cells.
Descriptor ID |
D008562
|
MeSH Number(s) |
D12.776.395.550 D12.776.543.550
|
Concept/Terms |
Membrane Glycoproteins- Membrane Glycoproteins
- Glycoproteins, Membrane
- Cell Surface Glycoproteins
- Glycoproteins, Cell Surface
- Surface Glycoproteins, Cell
- Cell Surface Glycoprotein
- Glycoprotein, Cell Surface
- Surface Glycoprotein, Cell
- Surface Glycoproteins
- Glycoproteins, Surface
- Surface Glycoprotein
- Glycoprotein, Surface
- Membrane Glycoprotein
- Glycoprotein, Membrane
|
Below are MeSH descriptors whose meaning is more general than "Membrane Glycoproteins".
Below are MeSH descriptors whose meaning is more specific than "Membrane Glycoproteins".
This graph shows the total number of publications written about "Membrane Glycoproteins" by people in this website by year, and whether "Membrane Glycoproteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 5 | 1 | 6 |
1996 | 7 | 2 | 9 |
1997 | 6 | 1 | 7 |
1998 | 12 | 5 | 17 |
1999 | 11 | 5 | 16 |
2000 | 15 | 5 | 20 |
2001 | 11 | 3 | 14 |
2002 | 13 | 7 | 20 |
2003 | 9 | 7 | 16 |
2004 | 9 | 9 | 18 |
2005 | 8 | 13 | 21 |
2006 | 6 | 2 | 8 |
2007 | 6 | 2 | 8 |
2008 | 6 | 4 | 10 |
2009 | 5 | 5 | 10 |
2010 | 7 | 5 | 12 |
2011 | 3 | 2 | 5 |
2012 | 4 | 6 | 10 |
2013 | 9 | 4 | 13 |
2014 | 2 | 5 | 7 |
2015 | 2 | 0 | 2 |
2016 | 6 | 3 | 9 |
2017 | 6 | 3 | 9 |
2018 | 3 | 4 | 7 |
2019 | 3 | 0 | 3 |
2020 | 2 | 6 | 8 |
2021 | 6 | 3 | 9 |
2022 | 0 | 5 | 5 |
2023 | 1 | 4 | 5 |
2024 | 1 | 3 | 4 |
2025 | 1 | 3 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Membrane Glycoproteins" by people in Profiles.
-
GALNTL5 binds GalNAc and is required for migration through the uterotubal junction and sperm-zona pellucida binding. Nat Commun. 2025 Sep 17; 16(1):8264.
-
RNA Sequence Analysis in Macrophages Infected With Trypanosoma cruzi: Focus on TLR2 and TLR7, Iron Metabolism, and Extracellular Matrix Biosynthesis. J Infect Dis. 2025 Jul 11; 231(6):e1102-e1113.
-
Efficacy and safety of entrectinib in children with extracranial solid or central nervous system (CNS) tumours harbouring NTRK or ROS1 fusions. Eur J Cancer. 2025 May 02; 220:115308.
-
Speech, Language and Non-verbal Communication in CLN2 and CLN3 Batten Disease. J Inherit Metab Dis. 2025 01; 48(1):e12838.
-
Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression. Cancer Res Commun. 2024 12 01; 4(12):3209-3223.
-
Phase I dose escalation study of IO-108, an anti-LILRB2 antibody, in patients with advanced solid tumors. J Immunother Cancer. 2024 Nov 20; 12(11).
-
Comparing neoantigen cancer vaccines and immune checkpoint therapy unveils an effective vaccine and anti-TREM2 macrophage-targeting dual therapy. Cell Rep. 2024 11 26; 43(11):114875.
-
A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder Cancer. Cancer Res Commun. 2024 09 01; 4(9):2444-2453.
-
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy. Nature. 2024 Aug; 632(8023):182-191.
-
Challenges and rewards of in vivo synaptic density imaging, and its application to the study of depression. Neuropsychopharmacology. 2024 Nov; 50(1):153-163.